Comparative safety of sulfonylureas among U.S. nursing home residents.

Andrew R Zullo Melissa R RiesterKaleen N HayesMedha N MunshiSarah D Berry

Published in: Journal of the American Geriatrics Society (2022)

Among long-stay NH residents, new use of glimepiride and standard SU doses resulted in higher rates of severe hypoglycemic events. Cardiovascular outcomes may not be affected by the choice of SU medication or dose.

Keyphrases

early onset
healthcare
room temperature
adverse drug
decision making
drug induced
perovskite solar cells